Praxis Precision Medicines, Inc. Common Stock (PRAX) News
Latest headlines that mention PRAX, newest first · each headline opens the original publisher
- Last price
- $241.76
- Day change
- -2.61%
- Next earnings
- 2026-11-04
PRAX headlines
latest coverageTwo FDA applications advance as cash runway extends into 2028.
Praxis Precision Medicines unexpectedly halted enrollment in a late-stage study of its seizure drug. Praxis stock tumbled. The post The Shocking Twist That Sent This Seizure-Focused Biotech Into A Dive appeared first on Investor's Business Daily .
Image source: The Motley Fool. Thursday, May 7, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
PRAX news alerts
Get an alert by email or push when a new headline mentions PRAX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.